168 related articles for article (PubMed ID: 28542718)
21. Diagnosis and classification of hematologic malignancies on the basis of genetics.
Taylor J; Xiao W; Abdel-Wahab O
Blood; 2017 Jul; 130(4):410-423. PubMed ID: 28600336
[TBL] [Abstract][Full Text] [Related]
22. Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis.
Masarova L; Bose P; Daver N; Pemmaraju N; Newberry KJ; Manshouri T; Cortes J; Kantarjian HM; Verstovsek S
Leuk Res; 2017 Aug; 59():110-116. PubMed ID: 28601551
[TBL] [Abstract][Full Text] [Related]
23. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
Faries MB; Thompson JF; Cochran AJ; Andtbacka RH; Mozzillo N; Zager JS; Jahkola T; Bowles TL; Testori A; Beitsch PD; Hoekstra HJ; Moncrieff M; Ingvar C; Wouters MWJM; Sabel MS; Levine EA; Agnese D; Henderson M; Dummer R; Rossi CR; Neves RI; Trocha SD; Wright F; Byrd DR; Matter M; Hsueh E; MacKenzie-Ross A; Johnson DB; Terheyden P; Berger AC; Huston TL; Wayne JD; Smithers BM; Neuman HB; Schneebaum S; Gershenwald JE; Ariyan CE; Desai DC; Jacobs L; McMasters KM; Gesierich A; Hersey P; Bines SD; Kane JM; Barth RJ; McKinnon G; Farma JM; Schultz E; Vidal-Sicart S; Hoefer RA; Lewis JM; Scheri R; Kelley MC; Nieweg OE; Noyes RD; Hoon DSB; Wang HJ; Elashoff DA; Elashoff RM
N Engl J Med; 2017 Jun; 376(23):2211-2222. PubMed ID: 28591523
[TBL] [Abstract][Full Text] [Related]
24. Calreticulin in Essential Thrombocythemia: StressINg OUT the Megakaryocyte Nucleus.
Iborra FJ; Papadopoulos P
Front Oncol; 2017; 7():103. PubMed ID: 28589084
[TBL] [Abstract][Full Text] [Related]
25. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
[TBL] [Abstract][Full Text] [Related]
26. The mutant CALR allele burden in essential thrombocythemia at transformation to acute myeloid leukemia.
Langabeer SE; Haslam K; Elhassadi E
Blood Cells Mol Dis; 2017 Jun; 65():66-67. PubMed ID: 28552475
[No Abstract] [Full Text] [Related]
27. Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
Stone RM; Mandrekar SJ; Sanford BL; Laumann K; Geyer S; Bloomfield CD; Thiede C; Prior TW; Döhner K; Marcucci G; Lo-Coco F; Klisovic RB; Wei A; Sierra J; Sanz MA; Brandwein JM; de Witte T; Niederwieser D; Appelbaum FR; Medeiros BC; Tallman MS; Krauter J; Schlenk RF; Ganser A; Serve H; Ehninger G; Amadori S; Larson RA; Döhner H
N Engl J Med; 2017 Aug; 377(5):454-464. PubMed ID: 28644114
[TBL] [Abstract][Full Text] [Related]
28. Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis.
Eapen M; Wang T; Veys PA; Boelens JJ; St Martin A; Spellman S; Bonfim CS; Brady C; Cant AJ; Dalle JH; Davies SM; Freeman J; Hsu KC; Fleischhauer K; Kenzey C; Kurtzberg J; Michel G; Orchard PJ; Paviglianiti A; Rocha V; Veneris MR; Volt F; Wynn R; Lee SJ; Horowitz MM; Gluckman E; Ruggeri A
Lancet Haematol; 2017 Jul; 4(7):e325-e333. PubMed ID: 28623181
[TBL] [Abstract][Full Text] [Related]
29. Association Between Persistent Pain and Memory Decline and Dementia in a Longitudinal Cohort of Elders.
Whitlock EL; Diaz-Ramirez LG; Glymour MM; Boscardin WJ; Covinsky KE; Smith AK
JAMA Intern Med; 2017 Aug; 177(8):1146-1153. PubMed ID: 28586818
[TBL] [Abstract][Full Text] [Related]
30. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
31. A rapid and systemic complete response to stereotactic body radiation therapy and pembrolizumab in a patient with metastatic renal cell carcinoma.
Xie G; Gu D; Zhang L; Chen S; Wu D
Cancer Biol Ther; 2017 Aug; 18(8):547-551. PubMed ID: 28665741
[TBL] [Abstract][Full Text] [Related]
32. Intraosseous hemangioblastoma of the cervical spine: case report.
Li Z; Curtis B; Layser R; Selvarajan SK; Harrop J; Kenyon LC; Parsons T; Rubin A
J Neurosurg Spine; 2017 Sep; 27(3):312-315. PubMed ID: 28665246
[TBL] [Abstract][Full Text] [Related]
33. Everolimus-induced nephrotic syndrome precipitated by interaction with voriconazole in a patient with Hodgkin's lymphoma.
Tran PN; Pinter-Brown LC
J Clin Pharm Ther; 2017 Dec; 42(6):776-779. PubMed ID: 28661568
[TBL] [Abstract][Full Text] [Related]
34. Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report.
Lolli I; Stasi E; Fucilli F; Pirrelli M; Armentano R; Campanella G; Lotesoriere C; Lorusso D
Medicine (Baltimore); 2017 Jun; 96(26):e7273. PubMed ID: 28658123
[TBL] [Abstract][Full Text] [Related]
35. High-grade poorly differentiated neuroendocrine carcinoma of the breast with low oncotype Dx recurrence score: A case report.
Munoz-Zuluaga CA; Kotiah S; Studeman KD
Breast Dis; 2017; 37(2):99-103. PubMed ID: 28655121
[TBL] [Abstract][Full Text] [Related]
36. Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial.
Tap WD; Papai Z; Van Tine BA; Attia S; Ganjoo KN; Jones RL; Schuetze S; Reed D; Chawla SP; Riedel RF; Krarup-Hansen A; Toulmonde M; Ray-Coquard I; Hohenberger P; Grignani G; Cranmer LD; Okuno S; Agulnik M; Read W; Ryan CW; Alcindor T; Del Muro XFG; Budd GT; Tawbi H; Pearce T; Kroll S; Reinke DK; Schöffski P
Lancet Oncol; 2017 Aug; 18(8):1089-1103. PubMed ID: 28651927
[TBL] [Abstract][Full Text] [Related]
37. Complete molecular remission in relapsed and refractory acute myeloid leukaemia with MLL-AF9 treated with chidamide-based chemotherapy.
Lun Y; Yang JJ; Wu Y
J Clin Pharm Ther; 2017 Dec; 42(6):786-789. PubMed ID: 28646565
[TBL] [Abstract][Full Text] [Related]
38. Bruton's tyrosine kinase (BTK) as a promising target in solid tumors.
Molina-Cerrillo J; Alonso-Gordoa T; Gajate P; Grande E
Cancer Treat Rev; 2017 Jul; 58():41-50. PubMed ID: 28641100
[TBL] [Abstract][Full Text] [Related]
39. Genomic Profiling of Small-Bowel Adenocarcinoma.
Schrock AB; Devoe CE; McWilliams R; Sun J; Aparicio T; Stephens PJ; Ross JS; Wilson R; Miller VA; Ali SM; Overman MJ
JAMA Oncol; 2017 Nov; 3(11):1546-1553. PubMed ID: 28617917
[TBL] [Abstract][Full Text] [Related]
40. Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial.
Shaw AT; Kim TM; Crinò L; Gridelli C; Kiura K; Liu G; Novello S; Bearz A; Gautschi O; Mok T; Nishio M; Scagliotti G; Spigel DR; Deudon S; Zheng C; Pantano S; Urban P; Massacesi C; Viraswami-Appanna K; Felip E
Lancet Oncol; 2017 Jul; 18(7):874-886. PubMed ID: 28602779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
